LD6 Stock Overview
Core One Labs Inc. operates as a psychedelic research and development company.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Core One Labs Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.13 |
52 Week High | CA$0.46 |
52 Week Low | CA$0.025 |
Beta | 1.66 |
1 Month Change | -16.98% |
3 Month Change | -32.41% |
1 Year Change | -59.61% |
3 Year Change | -96.69% |
5 Year Change | -99.56% |
Change since IPO | -97.20% |
Recent News & Updates
Recent updates
Shareholder Returns
LD6 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 0% | 0.9% | -1.0% |
1Y | -59.6% | -27.7% | 2.0% |
Return vs Industry: LD6 underperformed the German Pharmaceuticals industry which returned -27.7% over the past year.
Return vs Market: LD6 underperformed the German Market which returned 2% over the past year.
Price Volatility
LD6 volatility | |
---|---|
LD6 Average Weekly Movement | 17.9% |
Pharmaceuticals Industry Average Movement | 7.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LD6's share price has been volatile over the past 3 months.
Volatility Over Time: LD6's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | Joe Shacker | core1labs.com |
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation.
Core One Labs Inc. Fundamentals Summary
LD6 fundamental statistics | |
---|---|
Market cap | €7.36m |
Earnings (TTM) | -€10.85m |
Revenue (TTM) | €311.36k |
23.6x
P/S Ratio-0.7x
P/E RatioIs LD6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LD6 income statement (TTM) | |
---|---|
Revenue | CA$458.54k |
Cost of Revenue | CA$0 |
Gross Profit | CA$458.54k |
Other Expenses | CA$16.44m |
Earnings | -CA$15.98m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.34 |
Gross Margin | 100.00% |
Net Profit Margin | -3,485.36% |
Debt/Equity Ratio | 4.2% |
How did LD6 perform over the long term?
See historical performance and comparison